tiprankstipranks
Everest Medicines Ltd. (HK:1952)
:1952
Hong Kong Market
Want to see HK:1952 full AI Analyst Report?

Compare Everest Medicines Ltd. (1952) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Everest Medicines Ltd.
HK$51.50
HK$10.91B
-34.56%
2 Buy
0 Hold
0 Sell
Moderate Buy
InnoCare Pharma Ltd.
HK$11.75
HK$17.95B
50.10
18.24%
3 Buy
0 Hold
0 Sell
Strong Buy
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$8.25B
9.33
3.21%
1 Buy
0 Hold
0 Sell
Moderate Buy
Keymed Biosciences, Inc.
HK$62.80
HK$17.70B
-8.22
51.27%
3 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$10.80B
-86.94
-7.52%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Haohai Biological Technology Co., Ltd. Class H
HK$24.90
HK$8.85B
15.02
-14.11%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1952
Everest Medicines Ltd.
30.66
-14.94
-32.76%
HK:9969
InnoCare Pharma Ltd.
12.06
1.08
9.84%
HK:2157
Lepu Biopharma Co. Ltd. Class H
4.50
0.03
0.67%
HK:2162
Keymed Biosciences, Inc.
62.55
20.35
48.22%
HK:2171
CARsgen Therapeutics Holdings Ltd.
18.20
-3.40
-15.74%
HK:6826
Shanghai Haohai Biological Technology Co., Ltd. Class H
20.70
-4.01
-16.23%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts